Pharming Group NV (PHAR) — Cash Flow-to-Debt Ratio
Pharming Group NV (PHAR) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of $1.63 Million could theoretically repay 0% of its total liabilities ($220.41 Million) in one year. Explore PHAR long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharming Group NV Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Pharming Group NV across 21 annual periods. Also explore Pharming Group NV assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Pharming Group NV (2005–2025)
Year-by-year debt coverage analysis for Pharming Group NV. For market capitalisation and broader financial context, see Pharming Group NV (PHAR) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | $50.07 Million | $222.79 Million | ▲ +2340.0% |
| 2024 | -0.01x | $-1.79 Million | $178.92 Million | ▲ +85.8% |
| 2023 | -0.07x | $-17.30 Million | $244.07 Million | ▼ -169.8% |
| 2022 | 0.10x | $22.46 Million | $221.16 Million | ▼ -45.2% |
| 2021 | 0.19x | $37.84 Million | $204.40 Million | ▼ -57.4% |
| 2020 | 0.43x | $83.63 Million | $192.39 Million | ▼ -18.8% |
| 2019 | 0.54x | $74.15 Million | $138.53 Million | ▲ +102.6% |
| 2018 | 0.26x | $46.19 Million | $174.81 Million | ▲ +1.9% |
| 2017 | 0.26x | $45.84 Million | $176.82 Million | ▲ +357.4% |
| 2016 | -0.10x | $-10.52 Million | $104.45 Million | ▲ +79.2% |
| 2015 | -0.49x | $-17.95 Million | $37.00 Million | ▼ -137.9% |
| 2014 | -0.20x | $-6.42 Million | $31.46 Million | ▲ +35.1% |
| 2013 | -0.31x | $-11.45 Million | $36.45 Million | ▲ +25.1% |
| 2012 | -0.42x | $-13.58 Million | $32.40 Million | ▲ +30.9% |
| 2011 | -0.61x | $-20.34 Million | $33.55 Million | ▼ -218.4% |
| 2010 | -0.19x | $-6.89 Million | $36.16 Million | ▲ +57.4% |
| 2009 | -0.45x | $-27.24 Million | $60.99 Million | ▼ -138.7% |
| 2008 | -0.19x | $-14.21 Million | $75.96 Million | ▲ +31.4% |
| 2007 | -0.27x | $-31.69 Million | $116.14 Million | ▲ +59.3% |
| 2006 | -0.67x | $-25.89 Million | $38.59 Million | ▲ +69.5% |
| 2005 | -2.20x | $-15.26 Million | $6.93 Million | — |